Natco launches Semaglutide vials in India after patent expiry Natco's vials are 70% cheaper than pen devices, boosting access Dr Reddy's and Emcure shares rise as Semaglutide patent expires Shares of ...

https://www.thehindubusinessline.com/companies/natco-pharma-launches-generic-semaglutide-injection-in-india/article70764288.ece Copy Natco Pharma has launched the ...

To learn more about the CNBC CFO Council, visit cnbccouncils.com/cfo Nearly half of U.S. generic prescriptions originate in India, which relies on the Strait of ...

In the era of A.I. agents, many Silicon Valley programmers are now barely programming. Instead, what they’re doing is deeply, deeply weird. Credit...Illustration by Pablo Delcan and Danielle Del Plato ...

After delivering solid sales growth in a difficult 2025, Germany’s Merck KGaA may have a tougher go of things this year, which the company is crediting in part to a predicted onslaught of U.S.

BuyCanadianInsulin.com reports that generic semaglutide may become available in Canada in 2026 following changes in regulatory protections associated with the medication. The development reflects a ...

Africa’s largest drugmaker expects to get approval in Canada for its generic GLP-1 obesity treatment by September, potentially giving it an early start in a key market after Novo Nordisk A/S’s Ozempic ...

Voters are closely split over which party they prefer in the November midterm elections, but Democrats hold a wide advantage in voter enthusiasm over Republicans that could help them reclaim at least ...

The following is a news release from the Idaho Attorney General's Office: BOISE, Idaho — On February 2, 2026, Attorney General Labrador joined a coalition of 48 states and territories announcing ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Andres Almiray, a serial open-source ...

Oklahomans who purchased certain generic prescription drugs between 2009 and 2019 may be eligible for compensation after two pharmaceutical companies agreed to pay $17.85 million to settle allegations ...

Oklahomans who purchased certain generic prescription drugs between 2009 and 2019 may be eligible for compensation after two pharmaceutical companies agreed to pay $17.85 million to settle allegations ...